Skip to main content
Clinical Trials/NCT02776046
NCT02776046
Unknown
Not Applicable

Individualized Perioperative Open-luna Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction (iPROVE-O2). A Comparative, Prospective, Multicenter, Randomized Controlled Trial

Fundación para la Investigación del Hospital Clínico de Valencia1 site in 1 country756 target enrollmentJune 1, 2017

Overview

Phase
Not Applicable
Intervention
High FiO2
Conditions
Hyperoxia
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Enrollment
756
Locations
1
Primary Endpoint
Surgical site infection
Last Updated
8 years ago

Overview

Brief Summary

The iPROVE-O2 trial aims at comparing the efficacy of high and conventional FiO2 within a perioperative individualized ventilatory strategy to reduce the overall incidence of SSI.

Registry
clinicaltrials.gov
Start Date
June 1, 2017
End Date
February 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Responsible Party
Principal Investigator
Principal Investigator

Carlos Ferrando

MD,PhD

Fundación para la Investigación del Hospital Clínico de Valencia

Eligibility Criteria

Inclusion Criteria

  • Age not less than 18
  • Planned abdominal surgery\> 2 hours.
  • Signed informed consent for participation in the study.

Exclusion Criteria

  • Age less than 18 years.
  • Pregnant or breast-feeding.
  • Patients with BMI \>
  • Syndrome of moderate or severe respiratory distress: PaO2/FiO2 \< 200 mmHg.
  • Heart failure: NYHA IV.
  • Hemodynamic failure: CI \<2.5 L/min/m2 and / or requirements before surgery ionotropic support.
  • Diagnosis or suspicion of intracranial hypertension (intracranial pressure\> 15 mmHg).
  • Mechanical ventilation in the last 15 days.
  • Presence of pneumothorax. Presence of giant bullae on chest radiography or computed tomography (CT).
  • Patient with preoperatively CPAP.

Arms & Interventions

High FiO2

Intraoperatively ventilated patients with a tidal volume (VT) of 8 ml / kg of ideal body weight, and a FiO2 of 0.8. After intubation, all patients were conduct an alveolar recruitment maneuver (MRA) and PEEP level individualized spanned (see Calculation of optimal PEEP). Every 40 minutes will be assessed the need to adjust the level of PEEP by evaluating the dynamic compliance of the respiratory system (Crs). Faced with a decline in Crs\> 10% a new MRA and optimal PEEP setting will be assessed. Postoperatively 3h with 0.8 FiO2 and individualized CPAP

Intervention: High FiO2

Conventional FiO2

Intraoperatively ventilated patients with a tidal volume (VT) of 8 ml / kg of ideal body weight, and a FiO2 of 0.3. After intubation, all patients were conduct an alveolar recruitment maneuver (MRA) and PEEP level individualized spanned (see Calculation of optimal PEEP). Every 40 minutes will be assessed the need to adjust the level of PEEP by evaluating the dynamic compliance of the respiratory system (Crs). Faced with a decline in Crs\> 10% a new MRA and optimal PEEP setting will be assessed. Postoperatively 3h with 0.3 FiO2 and individualized CPAP

Intervention: Conventional FiO2

Outcomes

Primary Outcomes

Surgical site infection

Time Frame: seven postoperative days

Secondary Outcomes

  • Systemic complications(seven postoperative days)
  • Systemic and pulmonary complications(thirty postoperative days)
  • Pulmonary complications(seven postoperative days)

Study Sites (1)

Loading locations...

Similar Trials